poisar

Stocks · News reference

BTIG Reiterates Buy on Bright Minds Biosciences, Maintains $147 Price Target

Aug 17, 2026, 4:24 PMBenzinga Newsdesk

BTIG analyst Thomas Shrader reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maintains $147 price target.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

DRUG
Source
benzinga
Observed
Aug 17, 2026, 4:24 PM
Checked
Aug 17, 2026, 4:24 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading